By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Selexis SA 

177 Post Street, Suite 900

San Francisco  California  94108  U.S.A.
Phone: 415-273-5141 Fax: 415-421-5510



Start Up

Company News
Selexis SA Announces Spring 2016 Conference Schedule 3/31/2016 11:46:27 AM
Selexis SA Announces Spring 2016 Conference Schedule 3/31/2016 9:53:46 AM
Complix NV Advances Novel Biospecific Immunotherapeutic CMX-02 - Enters Agreement With Selexis SA To Access SUREtechnology Platform 12/14/2015 8:50:22 AM
Faron Pharmaceuticals Ltd. Enters Agreement With Selexis SA To Progress Development Of Novel Cancer Immunotherapy Clevegen 11/3/2015 9:26:41 AM
Selexis SA Announces Service Agreement With Swedish Orphan Biovitrum 9/22/2015 9:29:09 AM
Merus And Selexis SA Receive A € 2.1 Million Grant For Single Cell Line Manufacturing Of A Bispecific Antibody Combination To Treat Colorectal Cancer 5/20/2015 10:07:20 AM
Ligand Pharmaceuticals Inc. (LGND) Acquires Rights To More Than 15 Fully-Funded Development Programs From Selexis SA 5/11/2015 8:01:34 AM
Selexis SA Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 1/23/2015 11:34:16 AM
First Selexis SA SUREtechnology Generated Therapeutic Monoclonal Antibody Approved For Market 1/8/2015 11:11:41 AM
Symphogen A/S Licenses The Selexis SA SUREtechnology Expression Platform And Cell Line 12/9/2014 11:29:21 AM